eNewsroom for: Kibow Biotech Inc.

http://pressreleaseheadlines.com/wp-content/Cimy_User_Extra_Fields/Kibow Biotech Inc./Screen-Shot-2013-11-14-at-10.02.05-AM.png

Kibow Biotech Inc. Company Profile

Kibow Biotech, Inc. develops groundbreaking methods of using probiotics (beneficial bacteria) to bring hope to kidney failure patients worldwide. With our scientifically formulated dietary supplements, we also address metabolic syndrome patients who are at an elevated long-term risk of developing chronic kidney failure (CKF).

News from Kibow Biotech Inc.:

Kibow Biotech To Showcase Renadyl™ and Support ASN 2014 Theme For Kidney Health in Philadelphia

NEWTOWN SQUARE, Pa., Nov. 11, 2014 /PRNewswire/ – The American Society Of Nephrology (ASN) and more than 13,000 other kidney professionals from across the globe will be participating at Kidney Week 2014 in Philadelphia Convention Center, Pennsylvania. The world's premier nephrology…

Kibow Biotech Presents Renadyl Story about Kidney Function at Harvard Medical School Probiotics Symposium

NEWTOWN SQUARE, Pa., Sept. 22, 2014 /PRNewswire/ — The Harvard Medical School – Division of Nutrition will be hosting its annual symposium on probiotics on Sept 22 and 23 in Boston, MA. This symposium is intended to provide an overview of the latest scientific evidence related to gut microbiota…

Kibow Biotech — A "Buzz of BIO" Award Winner Presenting Investment/Business Opportunity on Emerging Field of "Gut Microbiome" with Probiotics and Prebiotics

NEWTOWN SQUARE, Pa., June 16, 2014 /PRNewswire/ – Kibow Biotech, Inc., an internationally-recognized research company, and winner of a 2014 BIO International Convention "Buzz of BIO Award", is the first biotechnology company specializing exclusively in dietary supplement pr…

Pennsylvania Probiotic Dietary Supplement Company Wins Biotech Innovation Award

NEWTOWN SQUARE, Pa., May 7, 2014 /PRNewswire/ – Kibow Biotech is delighted to be announced a winner of this year's BIO International Convention (June 23 – 26), Buzz of BIO Contest. The Pennsylvania based company is one of the four winners in this year's contest recognizing the most…

Kibow Biotech of Newtown Square, Pennsylvania — First Dietary Supplement Company, Nominated to Participate in the "Buzz of BIO"- Pipelines of Promise Category at the 2014 BIO International Convention.

NEWTOWN SQUARE, Pa., April 15, 2014 /PRNewswire/ — Kibow Biotech is pleased to participate in the Buzz of BIO for the 2014 BIO International Convention. Hosted by the Biotechnology Industry Organization (BIO), this year's global event for biotechnology will take place June 23-26, 2014 at…

Kibow Biotech Joins with Apollo Hospital Group to Celebrate Dr. Eli Friedman and His Contribution to the Field of Nephrology with Lifetime Achievement Award

NEWTOWN SQUARE, Pa., March 14, 2014 /PRNewswire/ – Kibow Biotech is pleased to announce that March 13, on the occasion of World Kidney Day (worldkidneyday.org), it joined with Apollo Hospital Group (Chennai, India) to honor Dr. Eli A. Friedman, M.D., M.A.C.P., F.A.C.P., with a Lifetime Achie…

Kibow Biotech Marks World Kidney Day with Introduction of Renadyl™ Product to India Market

Product launch to coincide with 9th Nutra India Summit in Bangalore
NEWTOWN SQUARE, Pa., March 13, 2014 /PRNewswire/ – Kibow Biotech is pleased to announce that it will mark World Kidney Day (March 13, worldkidneyday.org) with the launch of Renadyl™, its patented, clinically validated p…

Kibow Biotech Achieves Major Victory with India's IPAB Decision to Uphold 2009 Product Patent

NEWTOWN SQUARE, Pa., Dec. 2, 2013 /PRNewswire/ – The landmark decision by India's top IP body, the Intellectual Property Appellate Board (IPAB), to uphold Kibow Biotech's key product patent No: 224100 granted in the year 2009 by the government of India is a major victory for a small b…

Kibow Biotech Showcases Renadyl™ During Kidney Week ASN Convention in Atlanta Nov. 7-9

Company will present results from recent clinical trial, safety data and benefits of the probiotic dietary supplement for kidney health
NEWTOWN SQUARE, Pa., Nov. 4, 2013 /PRNewswire/ – A major annual event of the American Society of Nephrology (ASN) – The Kidney Week – is to be held Nov. 5-1…

Kibow Biotech to Educate the Educators on Renadyl™ Probiotics for Kidney Health Applications at AADE Conference in Philadelphia, PA

NEWTOWN SQUARE, Pa., Aug. 6, 2013 /PRNewswire/ – Kibow Biotech will present Renadyl™, the Company's probiotic formulation for kidney health, at the American Association of Diabetic Educators (AADE) Conference, to be held from Aug 8–10 at the Philadelphia Convention Center, PA.…

Future of Pre- and Probiotics to be Discussed by Kibow Biotech Founder During SupplySide MarketPlace 2013 Global Expo & Conference

NEWTOWN SQUARE, Pa., April 29, 2013 /PRNewswire/ – Dr. Natarajan Ranganathan, one of the founders and the managing director for R&D and Operations of Kibow Biotech, Inc., has been invited to deliver a talk as a part of an educational seminar on "Pre- & Probiotics – Market, Scien…

Kibow Biotech Marks Its Continued Growth with Relocation to Larger Facilities

NEWTOWN SQUARE, Pa., July 31, 2012 — Kibow Biotech Inc. (KIBOW) is pleased to announce its recent relocation to a custom-built probiotic R&D center dedicated to the development and commercialization of natural formulations (mainly targeting renal failure). The new 7500 sq. ft. center is l…

Kibow Biotech Showcases RENADYL™ at BIO 2012 Conference, Boston, MA

NEWTOWN SQUARE, Pa., June 18, 2012 — Kibow Biotech is pleased to announce their active participation in the 2012 BIO International Convention. Hosted by the Biotechnology Industry Organization (BIO), this year's global event for biotechnology will take place June 18-21, 2012 at the Bost…

Interim Clinical Trial Results Confirm Safety of Renadyl™, a Probiotic Dietary Supplement for the Support of Healthy Kidney Function

NEWTOWN SQUARE, Pa., March 8, 2012 — On the occasion of World Kidney Day, Kibow Biotech, Inc. is pleased to announce that interim data from an expanded clinical trial of Renadyl™ (http://www.Renadyl.com) confirms the positive results for safety and improved quality of life (QOL) previously e…

Kibow Changes Name of Flagship Kidney Function Support Product to 'RENADYL™'

NEWTOWN SQUARE, Pa., Nov. 8, 2011 — Kibow Biotech, Inc. (a suburban Philadelphia-based Company) announced today, at the occasion of Renal Week, it is changing the brand name of its flagship product to "RENADYL™." Formerly known as Kibow® Biotics, this patented and clinically tes…

Kibow Biotech, Inc. Secures $2.4 Million Towards Its Human Clinical Trials by Continued Veterinary Licensing Agreement

NEWTOWN SQUARE, Pa., Aug. 24, 2011 — Kibow Biotech, Inc. today announced that it has renewed its exclusive worldwide licensing and marketing agreement with the current licensing partner specializing in animal health. The agreement concerns "Azodyl™," a patented, 100% natural,…

Institutional Review Board Approval Obtained for Study of Kibow(R) Biotics in Dialysis Patients with End-stage Chronic Kidney Disease

PHILADELPHIA, March 10, 2011 — On the occasion of World Kidney Day, Kibow Biotech, Inc. is pleased to announce its renewed commitment, hope and support for the worldwide maintenance of healthy kidney function among all those people with kidney problems.
In addition, Kibow Biotech, Inc. would al…

Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health

PHILADELPHIA, Oct. 1, 2010 — Kibow has recently completed a pilot-scale study wherein Kibow(R) Biotics were administered orally to a limited number of patients in USA, Canada, Argentina and Nigeria. The positive outcome from this study has just been published in the September issue of the peer-…

Kibow Biotech Strongly Supports Kidney Disease Awareness and Education (KDAE) Week 2010!

PHILADELPHIA, Aug. 12, 2010 — Kibow Biotech would like to show its support for Kidney Disease Awareness and Education (KDAE) Week 2010, organized by American Nephrology Nurses' Association (ANNA). Kidney Disease Awareness and Education Week is a week dedicated to educating policymaker…

Kibow Biotech Selected to Present at the China Bio Partnering Forum 2010

NEWTOWN SQUARE, Pa., June 22, 2010 — Kibow Biotech, Inc. is pleased to announce that it has been selected as one of the six U.S.-based companies to present at the China Bio Partnering Forum to be held June 23-24, 2010, at Suzhou, China. At this prestigious event, a total of 36 companies from several co…

Kibow Biotech, Inc. to Present at BIO 2009 International Convention: Innovations to Heal, Fuel, and Feed the World

NEWTOWN SQUARE, Pa., May 14, 2009 — The Philadelphia area-based probiotics firm Kibow Biotech will be one of only three (3) Pennsylvania companies invited to present at the BIO 2009 Company Forum, , in Atlanta, GA on Tuesday, May 19. BIO is the world's largest biotechnology organization, pr…

Kibow Biotech, Inc. Launches Breakthrough Probiotic Dietary Supplement for Kidney Health in USA and Canada

NEWTOWN SQUARE, Pa., April 3, 2009 — After more than a decade of research and development, Kibow Biotech, Inc. announced today the launch of Kibow Biotics(R), the Company's new patented and proprietary probiotic formulation targeting kidney health. This product will be sold exclusively…

Kibow Biotech Strongly Supports World Kidney Day for Maintenance of Healthy Kidney Function

PHILADELPHIA, March 12, 2009 — On the occasion of World Kidney Day, Kibow Biotech, Inc. is pleased to announce that it will soon be introducing a breakthrough probiotic formulation as a scientifically formulated and clinically tested dietary supplement product, which, when taken regularly as…

Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure

PHILADELPHIA, Jan. 14, 2008 — Kibow Biotech, Inc. is pleased to announce that it has been granted an International Patent Cooperation Treaty (PCT) patent from Australia, China and India. The approved patent, "Prebiotic and Probiotic Compositions and their Method of use for Gut-based The…

Kibow Biotech Enters US Consumer Dietary Supplement Market with Kibow Flora(TM) and Three Related Products Targeting the Risk Factors of Metabolic Syndrome

PHILADELPHIA, Nov. 14, 2007 — Kibow Biotech, Inc. marked its first decade of activity by announcing today the launch of Kibow Flora(TM), the first probiotic and prebiotic combination specifically developed for Metabolic Syndrome. Metabolic Syndrome (also referred to as Syndrome-X), is a dis…